| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1157 | 22 | 1148 | 109 | 1327 | 231 | 1406 |
| ERLYTX | 80 | 1 | 52 | 9 | 110 | 20 | 122 |
| GI | 181 | 3 | 157 | 12 | 146 | 28 | 170 |
| GU | 358 | 7 | 365 | 24 | 292 | 46 | 280 |
| LEUK | 150 | 4 | 209 | 16 | 195 | 29 | 177 |
| LUNG | 193 | 1 | 52 | 10 | 122 | 34 | 207 |
| LYMPH | 409 | 14 | 730 | 53 | 645 | 92 | 560 |
| MELAN | 147 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 111 | 1 | 52 | 9 | 110 | 22 | 134 |
| MULT | 40 | 1 | 52 | 5 | 61 | 14 | 85 |
| OTHER | 54 | 0 | 0 | 4 | 49 | 11 | 67 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2881 | 54 | 2817 | 251 | 3057 | 527 | 3208 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 158 | 8 | 417 | 21 | 256 | 37 | 225 |
| ERLYTX | 10 | 0 | 0 | 1 | 12 | 3 | 18 |
| GU | 3 | 0 | 0 | 0 | 0 | 3 | 18 |
| LEUK | 633 | 10 | 522 | 59 | 718 | 114 | 694 |
| LUNG | 366 | 6 | 313 | 26 | 317 | 64 | 390 |
| OTHER | 36 | 0 | 0 | 4 | 49 | 6 | 37 |
| PEOLC | 110 | 0 | 0 | 0 | 0 | 1 | 6 |
| PREV | 220 | 3 | 157 | 25 | 304 | 43 | 262 |
| SXQOL | 614 | 19 | 991 | 63 | 767 | 129 | 785 |
| Total | 2150 | 46 | 2400 | 199 | 2423 | 400 | 2435 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1157 | 22 | 1148 | 109 | 1327 | 231 | 1406 |
| CCD | 158 | 8 | 417 | 21 | 256 | 37 | 225 |
| ERLYTX | 90 | 1 | 52 | 10 | 122 | 23 | 140 |
| GI | 181 | 3 | 157 | 12 | 146 | 28 | 170 |
| GU | 361 | 7 | 365 | 24 | 292 | 49 | 298 |
| LEUK | 783 | 14 | 730 | 75 | 913 | 143 | 871 |
| LUNG | 559 | 7 | 365 | 36 | 438 | 98 | 597 |
| LYMPH | 409 | 14 | 730 | 53 | 645 | 92 | 560 |
| MELAN | 147 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 111 | 1 | 52 | 9 | 110 | 22 | 134 |
| MULT | 40 | 1 | 52 | 5 | 61 | 14 | 85 |
| OTHER | 90 | 0 | 0 | 8 | 97 | 17 | 103 |
| PEOLC | 110 | 0 | 0 | 0 | 0 | 1 | 6 |
| PREV | 220 | 3 | 157 | 25 | 304 | 43 | 262 |
| SXQOL | 615 | 19 | 991 | 63 | 767 | 129 | 785 |
| Total | 5031 | 100 | 5216 | 450 | 5478 | 927 | 5642 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 730 | 13 | 678 | 63 | 767 | 132 | 804 |
| ERLYTX | 49 | 1 | 52 | 8 | 97 | 16 | 97 |
| GI | 133 | 3 | 157 | 10 | 122 | 23 | 140 |
| GU | 283 | 7 | 365 | 18 | 219 | 36 | 219 |
| LEUK | 94 | 3 | 157 | 10 | 122 | 19 | 116 |
| LUNG | 121 | 1 | 52 | 5 | 61 | 20 | 122 |
| LYMPH | 268 | 7 | 365 | 30 | 365 | 58 | 353 |
| MELAN | 97 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 68 | 0 | 0 | 4 | 49 | 12 | 73 |
| MULT | 15 | 0 | 0 | 0 | 0 | 5 | 30 |
| OTHER | 54 | 0 | 0 | 4 | 49 | 11 | 67 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1913 | 35 | 1826 | 152 | 1851 | 332 | 2021 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 130 | 4 | 209 | 13 | 158 | 24 | 146 |
| ERLYTX | 10 | 0 | 0 | 1 | 12 | 3 | 18 |
| GU | 3 | 0 | 0 | 0 | 0 | 3 | 18 |
| LEUK | 271 | 4 | 209 | 20 | 244 | 48 | 292 |
| LUNG | 227 | 3 | 157 | 15 | 183 | 33 | 201 |
| OTHER | 36 | 0 | 0 | 4 | 49 | 6 | 37 |
| PEOLC | 80 | 0 | 0 | 0 | 0 | 1 | 6 |
| PREV | 220 | 3 | 157 | 25 | 304 | 43 | 262 |
| SXQOL | 441 | 16 | 835 | 46 | 560 | 100 | 609 |
| Total | 1418 | 30 | 1567 | 124 | 1510 | 261 | 1589 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 910 | 20 | 1044 | 80 | 974 | 159 | 968 |
| CCD | 164 | 8 | 417 | 17 | 207 | 38 | 231 |
| ERLYTX | 59 | 1 | 52 | 9 | 110 | 19 | 116 |
| GI | 137 | 3 | 157 | 11 | 134 | 24 | 146 |
| GU | 315 | 7 | 365 | 14 | 170 | 46 | 280 |
| LEUK | 366 | 7 | 365 | 30 | 365 | 68 | 414 |
| LUNG | 367 | 4 | 209 | 29 | 353 | 65 | 396 |
| LYMPH | 268 | 7 | 365 | 30 | 365 | 58 | 353 |
| MELAN | 97 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 68 | 0 | 0 | 4 | 49 | 12 | 73 |
| MULT | 37 | 0 | 0 | 0 | 0 | 5 | 30 |
| OTHER | 226 | 0 | 0 | 8 | 97 | 30 | 183 |
| PEOLC | 79 | 0 | 0 | 1 | 12 | 2 | 12 |
| PREV | 220 | 3 | 157 | 25 | 304 | 43 | 262 |
| SXQOL | 442 | 16 | 835 | 46 | 560 | 100 | 609 |
| Total | 3755 | 76 | 3966 | 304 | 3700 | 669 | 4073 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 969 | 17 | 887 | 95 | 1157 | 210 | 1278 |
| ERLYTX | 74 | 1 | 52 | 9 | 110 | 17 | 103 |
| GI | 105 | 2 | 104 | 6 | 73 | 15 | 91 |
| GU | 234 | 6 | 313 | 22 | 268 | 35 | 213 |
| LEUK | 116 | 3 | 157 | 12 | 146 | 24 | 146 |
| LUNG | 163 | 1 | 52 | 10 | 122 | 32 | 195 |
| LYMPH | 340 | 13 | 678 | 50 | 609 | 81 | 493 |
| MMYEL | 97 | 1 | 52 | 8 | 97 | 20 | 122 |
| MULT | 40 | 1 | 52 | 5 | 61 | 14 | 85 |
| Total | 2138 | 45 | 2347 | 217 | 2643 | 448 | 2726 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1956 | 34 | 1774 | 159 | 1936 | 346 | 2106 |
| AFFIL | 138 | 6 | 313 | 12 | 146 | 23 | 140 |
| CCOP/NCORP | 1237 | 25 | 1304 | 105 | 1278 | 224 | 1364 |
| Non-SWOG | 1699 | 34 | 1774 | 173 | 2106 | 333 | 2027 |
| Total | 5030 | 99 | 5165 | 449 | 5466 | 926 | 5637 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | S2419 | Renal, adv clear cell, IO +/- Biotx, BIOFRONT | 1 | Y | 22-APR-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | NRGGU008 | Pros,Node+, Abiraterone acetate + Apalutamide | 1 | E | 15-APR-26 |
| BREAST | NRGBR007 | Breast, Stg I, De-Escalation of Breast RT | 1 | E | 08-APR-26 |
| BREAST | NRGBR007 | Breast, Stg I, De-Escalation of Breast RT | 2 | E | 08-APR-26 |
| LUNG | S1933 | NSCLC, Stg II-III, RT + Atezo | 2 | N | 01-MAY-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 16 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 13 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 10 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 10 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 8 |
| SXQOL | NRGCC015 | E-Mindfulness After Breast Cancer | 1 | 7 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 1 | 5 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 2 | 4 |
| MMYEL | S1803 | MM, Maintenance, Len vs Len/Dara | 3 | 4 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 3 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 3 |
| LYMPH | S2114 | NHL, Rel/Ref, CD19 CAR-T +/- Consolidation | 1 | 3 |
| GU | S2312 | Pros, MCRPC, Cab +/- Carb | 1 | 3 |